Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain

Clinical trial NCT06445465 · COMPLETED

Trial details

NCT number: NCT06445465
Sponsor: Invicro
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Alpha-Synucleinopathy Parkinson's Disease Dementia With Lewy Bodies Multisystem Atrophy

Start date: 2020-12-24
Primary completion: 2024-11-26
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.